07:00 , Sep 12, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Colorectal cancer b-Catenin (CTNNB1); E-cadherin (CDH1; CD324); Fusobacterium nucleatum FadA Mouse studies suggest targeting Fusobacterium nucleatum could help treat colorectal cancer....